Nosocomial acinetobacter bacteraemia in HUSM

dc.contributor.authorHarun, Azian
dc.contributor.authorDeris, Zakuan Zainy
dc.contributor.authorJohari, Mohd Radzi
dc.date.accessioned2021-07-26T03:27:39Z
dc.date.available2021-07-26T03:27:39Z
dc.date.issued2011
dc.description.abstractAcinetoliacter ''IPP is a known nosocomial pathogen causing a wide range of clinical diseases such as pneumonia, wound infeCti_On·and ·bloodstream infections (Bsn. The clinical outcomes of acinetobacter BSI were compared to · other gram negative infections. The crude mortality ofacinetobacter BSI was 47.2%, which was signitlcantly greater than other gfafn .. negative BSI. We found that patients treated in intensive care units (ICU), who had longer ICU stays, who preSented with shock or coagulopathy, had prior exposure to carbapenems, had mechanical ventilation, were on a ventilator tbr longer periods, had a nasogastric tube, had an arterial catheter or had parenteral nutrition at a significantly greatei- risk of mortality due to acinetobacter BSL Patients presenting with septic shock or having a central venous catheter were independently at higher risk for mortality. Appropriateness of therapy reduced the mortality attributes of acinetobacter BSJ but did not significantly reduce crude mortality in acinetobacter BSJ patients. This study shows the importance of preventing acinetobacter BSI and the appropriate use of antimicrobial agents to reduce mortality.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/13844
dc.language.isoenen_US
dc.publisherPusat Pengajian Sains Perubatan, Universiti Sains Malaysiaen_US
dc.subjectAdnetohacteren_US
dc.titleNosocomial acinetobacter bacteraemia in HUSMen_US
dc.typeArticleen_US
Files
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: